Re Development Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
TripBorn, Inc. – Software Development Agreement (September 26th, 2016)

This Software Development Agreement (the "Agreement" or "Software Development Agreement") states the terms and conditions that govern the contractual agreement between TAKNIKI COMMUNICATIONS (INDIA) PRIVATE LIMITED having his principal place of business at 64 JAGAT PARK, GHATLODIA, AHMEDABAD 380061, GUJARAT, INDIA, (the "Developer"), and TRIPBORN, INC. having its principal place of business at 812 Venus Atlantis Corporate Park, Near Prahalad Nagar Garden, Satellite, Ahmedabad 380015, Gujarat, India (the "Client") who agrees to be bound by this Agreement.

TripBorn, Inc. – Software Development Agreement (July 19th, 2016)

This Software Development Agreement (the "Agreement" or "Software Development Agreement") states the terms and conditions that govern the contractual agreement between TAKNIKI COMMUNICATION (INDIA) PRIVATE LIMITED having his principal place of business at 64 JAGAT PARK, GHATLODIA, AHMEDABAD 380061, GUJARAT, INDIA, (the "Developer"), and ARNA GLOBAL, LLC having its principal place of business at 514 LOTHIAN WAY, ABINGDON, MD 21009, USA (the "Client") who agrees to be bound by this Agreement.

Glolex, Inc. – Software Development Agreement (Assigment) (June 13th, 2016)

Glolex, Inc. you ("Client") is hiring UAB Almax Group ("Technician") to build a website and do software development work. The following sets forth the agreement between these two parties and binds them both.

TripBorn, Inc. – Software Development Agreement (April 18th, 2016)

This Software Development Agreement (the "Agreement" or "Software Development Agreement") states the terms and conditions that govern the contractual agreement between TAKNIKI COMMUNICATION (INDIA) PRIVATE LIMITED having his principal place of business at 64 JAGAT PARK, GHATLODIA, AHMEDABAD 380061, GUJARAT, INDIA, (the "Developer"), and ARNA GLOBAL, LLC having its principal place of business at 514 LOTHIAN WAY, ABINGDON, MD 21009, USA (the "Client") who agrees to be bound by this Agreement.

Jarex Solutions Corp. – Software Development Agreement (March 25th, 2015)

This Software Development Agreement (the "Agreement") states the terms and conditions that govern the contractual agreement between Jarex Solutions Corp. having his principal place of business at Puces iela 47 dz.40, Riga, Latvia, LV-1082, (the "Developer"), and SIA PIT-STOP.LV having its principal place of business at Melluzu iela 1, Riga, LV-1067 (the "Client") who agrees to be bound by this Agreement.

Todex Corp. – Software Development Agreement (February 13th, 2015)

This Software Development Agreement ("Agreement") is made and effective this February 12, 2015, by and between Batona Motors ("Buyer") and Todex Corp. ("Developer").

Code Rebel Corp – Website and Software Development Agreement (November 24th, 2014)

BUMP NETWORKS will provide web and software development services to the CUSTOMER relating to the creation or modification of a website.

Code Rebel Corp – Website and Software Development Agreement (November 18th, 2014)

BUMP NETWORKS will provide web and software development services to the CUSTOMER relating to the creation or modification of a website.

Re: Development Agreement for the Omagine Project (March 19th, 2014)

The one million square meters of land for the Omagine Project (the "Omagine Plot") was given to the Ministry of Tourism ("MOT") by His Majesty for the purpose of developing the Omagine Project. Attached please find copies of the original Mulkiya and Krooki for the Omagine Plot.

Arkados Group – Arkados, Inc. Software Development Agreement (October 11th, 2013)

THIS SOFTWARE DEVELOPMENT AGREEMENT (this "Agreement") is made as of June 28th, 2013 (the "Effective Date") between Arkados, Inc., having an office at 211 Warren Street, Suite 320, Newark, New Jersey 07103 ("Developer") and Tatung Co., a Taiwan corporation having an office at 22, Chungshan North Road, 3rd Section, Taipei, Taiwan 104("Client").

ECLIPSE IDENTITY RECOGNITION Corp – Software Development Agreement (July 5th, 2013)
Elong – Software Development Agreement [Note: Translation From Original Agreement Written in Chinese] (May 11th, 2010)
Cormedix Inc – Manufacture Development Agreement (December 31st, 2009)

THIS MANUFACTURE AND DEVELOPMENT AGREEMENT (the "Agreement" or "Contract") is entered into as of March 05, 2007 (the "Effective Date"), by and between CORMEDIX INC. ("CorMedix"), a limited liability company having an office and place of business at 787 Seventh Avenue, New York, New York 10019, U.S.A., and EMCURE PHARMACEUTICALS USA, INC. ("Emcure") a New Jersey [corporation] with its principal place of business located at 21 B Cotters Lane, East Brunswick, New Jersey 08816.

Contango Oil & Gas Company – CONTERRA JOINT VENTURE DEVELOPMENT AGREEMENT (A Tax Partnership) (October 28th, 2009)

This Agreement (Agreement) is made and entered into effective as of October 1, 2009 (Effective Date) by and between PATARA OIL & GAS LLC (Patara, Venture Manager or Operator), a Delaware limited liability company, whose address is Three Allen Center, 333 Clay, Suite 3960, Houston, Texas 77002 and CONTERRA COMPANY, (Conterra or Non-Operator) a Delaware corporation, whose address is 3700 Buffalo Speedway, Suite 960, Houston, Texas 77098, and shall sometimes be referred to in this Agreement, singularly as Party or collectively as Parties or as Venture Manager, Operator and Non Operator, as applicable.

Healthcare Trust Of America I – Future Development Agreement (September 22nd, 2009)

THIS FUTURE DEVELOPMENT AGREEMENT (this Agreement) is made as of September 9, 2009 by and between HTA GREENVILLE, LLC, a Delaware limited liability company (REIT), and GREENVILLE HOSPITAL SYSTEM, a political subdivision organized under the laws of South Carolina (GHS). REIT and GHS are sometimes collectively referred to herein as the Parties and individually as a Party.

FLO Corp – FLO Corporation Software Development Agreement (November 29th, 2007)

This Agreement (the Agreement) is made and entered into as of this 29th day of May 2007 (the Effective Date), by and between FLO Corporation, a Delaware corporation having a place of business located at 12413 Willows Road NE, Kirkland, Washington 98034 (hereinafter FLO), and International RAM Associates, Inc., a Texas corporation, with its principal offices located at 11044 Research Boulevard, Suite D-200, Austin, Texas 78759 (hereinafter RAM).

John D Oil Gas – Joint Venture Development Agreement (August 9th, 2007)

THIS AGREEMENT, entered into by and between KYKUIT RESOURCES, LLC, an Ohio limited liability company, hereinafter designated and referred to as Operator, and HEMUS, LTD, a Texas limited liability company, hereinafter designated and referred to herein as Non-Operator.

Sona Mobile Holdings – Certain Information (Indicated by Asterisks) in This Exhibit Has Been Omitted and Filed Separately With the Securities and Exchange Commission. Confidential Treatment Has Been Requested With Respect to the Omitted Portion. Software Development Agreement (May 14th, 2007)

This SOFTWARE DEVELOPMENT AGREEMENT (''Agreement''), effective as of March 15, 2007 (the ''Effective Date''), is made by and between Sona Mobile Holdings Corp. (''Sona''), a Delaware corporation with offices at 245 Park Ave. 39th Floor, New York, NY 10167, and Daily Racing Form, LLC (''DRF''), a Delaware limited liability company with offices at 100 Broadway, 7th Floor, New York, NY 10005-1902. Capitalized terms used herein without definition shall have the respective meanings assigned thereto in Exhibit A.

GWS Technologies, Inc. – Software Development Agreement (December 29th, 2006)

This Software Development Agreement (the "Agreement") is made between First Responder Products Inc., a Delaware corporation (FRPI), and Steve Stubblefield (Developer).

Auriga Laboratories – Re: Development Agreement Termination (October 23rd, 2006)
Dyax Corp. And Debiopharm S.A. Restructure Development Agreement for DX-890 (Depelestat) in Pulmonary Disorders (December 21st, 2005)

CAMBRIDGE, MA and LAUSANNE, Switzerland, December 20, 2005 - Dyax Corp. (Nasdaq: DYAX) and Debiopharm S.A. today announced the restructuring of their long-standing development agreement for DX-890 (Depelestat), a recombinant inhibitor of human neutrophil elastase (hNE) discovered by Dyax and developed by Debiopharm, for the treatment of pulmonary disorders. Under the terms of the restructured agreement, Debiopharm will have exclusive worldwide rights for the development, manufacture and commercialization of a native form of DX-890 in cystic fibrosis (CF) and acute respiratory distress syndrome (ARDS).

TRX, Inc. – Amended and Restated Software Development Agreement (July 27th, 2005)

e-TRX LIMITED a company incorporated in England and Wales (registered no. 3841799), whose registered office is at Sutherland House, Russell Way, Crawley, West Sussex, RH10 1UH (ETRX); and

TRX, Inc. – Amended and Restated Software Development Agreement (June 17th, 2005)

e-TRX LIMITED a company incorporated in England and Wales (registered no. 3841799), whose registered office is at Sutherland House, Russell Way, Crawley, West Sussex, RH10 1UH (ETRX); and

Mphase Technologies – Software Development Agreement (April 18th, 2005)

This Development Agreement ("Agreement") is made and entered into by the undersigned parties: mPhase Technologies Inc., 150 Clove Road, a New Jersey corporation (hereinafter "COMPANY"), and Magpie Telecom Insiders, Inc, 12050 N. Pecos, Suite 210, Denver, Colorado, 80234, a Colorado corporation, (hereinafter "Contractor").

Mphase Technologies – Software Development Agreement (March 18th, 2005)

This Development Agreement ("Agreement") is made and entered into by the undersigned parties: mPhase Technologies Inc., 150 Clove Road, a New Jersey corporation (hereinafter "COMPANY"), and Magpie Telecom Insiders, Inc, 12050 N. Pecos, Suite 210, Denver, Colorado, 80234, a Colorado corporation, (hereinafter "Contractor").

Threshold Pharmaceuticals – Re: Development Agreement Between Threshold Pharmaceuticals, Inc., and MediBIC Co., Ltd. (January 28th, 2005)

I am writing you in regard to the Development Agreement between our companies having an Effective Date of 30 November 2004 and its accompanying side letter, both signed 2 December 2004. This letter confirms our understanding that, pursuant to the Development Agreement and side letter, Threshold has granted and hereby confirms its grant to MediBic of a non-exclusive license to use Threshold confidential information relating to glufosfamide for the limited purpose of preparing the Development Plan and any associated marketing plans as authorized under the Development Agreement, and if such Development Plan is agreed upon by the parties, this non-exclusive license to use Threshold confidential information shall continue for the time necessary for MediBIC to perform its obligations under the Development Plan.

This SOFTWARE DEVELOPMENT AGREEMENT (This "Agreement") Is Made at Vancouver, British Columbia, on December 1, 2002. By and Between: (May 10th, 2004)

Evove, Inc., a company incorporated under the laws of the State of Nevada, having its registered office at 1850 Lands End Road, Sidney, British Columbia, Canada V8L5J2 ("EVOVE")

Spectre Gaming Inc. Software Development Agreement (May 10th, 2004)

THIS SOFTWARE DEVELOPMENT AGREEMENT (the Agreement) is made as of March 4, 2004 (the Effective Date) between MET Games Inc., a corporation organized under the laws of the State of Oklahoma (MET) with a principal place of business located at 1611 S. Utica, #194, Tulsa, Oklahoma 74104, and Spectre Gaming Inc., a corporation organized under the laws of the State of Minnesota (Spectre) with a principal place of business located at 800 Nicollet Mall, Suite 2690, Minneapolis, Minnesota 55402. MET and Spectre are individually each a Party to this Agreement, and collectively referred to herein as the "Parties.